At the news
? NEUTRALIMPACT 5/10 8-K filed Feb 24, 2026 at 17:00 ET
NovoCure announced that CMS rescinded the prior revocation of its Medicare billing privileges, reinstating them retroactively to December 17, 2025. The revocation was due to an administrative issue, not a substantive failure, and the company continued patient services during the period, expecting no revenue impact.
- CMS revoked NovoCure's Medicare billing privileges retroactive to December 17, 2025, due to an administrative process issue with triannual re-validation.
- On February 24, 2026, CMS rescinded the revocation and reinstated billing privileges retroactively to December 17, 2025.
- The company continued providing services to existing and new patients during the period of ineligibility.
- NovoCure believes there will be no impact on its ability to recognize revenue for services provided during the lapse.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access